CD40-stimulated B Lymphocytes Pulsed with Tumor Antigens Are Effective Antigen-presenting Cells That Can Generate Specific T Cells
dc.contributor.author | Lapointe, Réjean | |
dc.contributor.author | Bellemare-Pelletier, Angélique | |
dc.contributor.author | Housseau, Frank | |
dc.contributor.author | Thibodeau, Jacques | |
dc.contributor.author | Hwu, Patrick | |
dc.date.accessioned | 2006-08-14T20:16:52Z | |
dc.date.available | 2006-08-14T20:16:52Z | |
dc.date.issued | 2003-06-01 | |
dc.identifier.uri | http://hdl.handle.net/1866/160 | |
dc.description.sponsorship | Intramural National Institutes of Health (NIH) program | en |
dc.format.extent | 280924 bytes | |
dc.format.mimetype | application/pdf | |
dc.publisher | HighWire Press (American Association for Cancer Research) | en |
dc.subject | Tumor antigen presentation; CD40-activated B lymphocytes | en |
dc.subject | CD4+ T lymphocytes; MHC class II; HLA-DO | en |
dc.title | CD40-stimulated B Lymphocytes Pulsed with Tumor Antigens Are Effective Antigen-presenting Cells That Can Generate Specific T Cells | en |
dc.type | Article | en |
dc.contributor.affiliation | Université de Montréal. Faculté de médecine. Département de médecine | fr |
dcterms.abstract | Although they are considered as antigen presenting cells (APC), the role of antigen-unspecific B-lymphocytes in antigen presentation and T lymphocyte stimulation remains controversial. In this paper, we tested the capacity of normal human peripheral activated B cells to stimulate T cells using melanoma antigens or melanoma cell lysates. B lymphocytes activated through CD40 ligation and then pulsed with tumor antigens efficiently processed and presented MHC class II restricted peptides to specific CD4+ T cell clones. This suggests that CD40-activated B cells have the functional and molecular competence to present MHC class II epitopes when pulsed with exogenous antigens, thereby making them a relevant source of APC to generate T cells. To test this hypothesis, CD40-activated B cells were pulsed with a lysate prepared from melanoma cells and used to stimulate peripheral autologous T cells. Interestingly, T cells specific to melanoma antigens were generated. Further analysis of these T cell clones revealed that they recognized MHC class II restricted epitopes from tyrosinase, a known melanoma tumor antigen. The efficient antigen presentation by antigen-unspecific activated B cells was correlated with a down-regulation in the expression of HLA-DO, a B cell specific protein known to interfere with HLA-DM function. Because HLA-DM is important in MHC class II peptide loading, the observed decrease in HLA-DO may partially explain the enhanced antigen presentation following B-cell activation. Results globally suggest that when they are properly activated, antigen-unspecific B-lymphocytes can present exogenous antigens by MHC class II molecules and stimulate peripheral antigen-specific T cells. Antigen presentation by activated B cells could be exploited for immunotherapy by allowing the in vitro generation of T cells specific against antigens expressed by tumors or viruses. | en |
dcterms.language | eng | en |
UdeM.VersionRioxx | Version acceptée / Accepted Manuscript | |
oaire.citationTitle | Cancer research | |
oaire.citationVolume | 63 | |
oaire.citationStartPage | 2836 | |
oaire.citationEndPage | 2843 |
Files in this item
This item appears in the following Collection(s)
This document disseminated on Papyrus is the exclusive property of the copyright holders and is protected by the Copyright Act (R.S.C. 1985, c. C-42). It may be used for fair dealing and non-commercial purposes, for private study or research, criticism and review as provided by law. For any other use, written authorization from the copyright holders is required.